Actively Recruiting
Bempedoic Acid Pregnancy Surveillance Program
Led by Esperion Therapeutics, Inc. · Updated on 2024-05-17
20
Participants Needed
1
Research Sites
556 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Bempedoic acid pregnancy surveillance program
CONDITIONS
Official Title
Bempedoic Acid Pregnancy Surveillance Program
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Exposure to at least 1 dose of bempedoic acid or bempedoic acid/ezetimibe fixed combination drug product at any time during pregnancy (from first day of last menstrual period to pregnancy outcome)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Evidera, PPD business unit
Morrisville, North Carolina, United States, 27560
Actively Recruiting
Research Team
E
Esperion Therapuetics
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here